Protease-activated receptor-1 impairs host defense in murine pneumococcal pneumonia: a controlled laboratory study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1364-8535
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Protease-activated receptor-1 impairs host defense in murine pneumococcal pneumonia: a controlled laboratory study ; volume:16 ; number:6 ; day:27 ; month:12 ; year:2012 ; pages:1-8 ; date:12.2012
Critical care ; 16, Heft 6 (27.12.2012), 1-8, 12.2012
- Creator
-
Schouten, Marcel
- Contributor
-
van't Veer, Cornelis
Roelofs, Joris JTH
Levi, Marcel
van der Poll, Tom
SpringerLink (Online service)
- DOI
-
10.1186/cc11910
- URN
-
urn:nbn:de:1111-201604229069
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schouten, Marcel
- van't Veer, Cornelis
- Roelofs, Joris JTH
- Levi, Marcel
- van der Poll, Tom
- SpringerLink (Online service)
Other Objects (12)
IL-37 Causes Excessive Inflammation and Tissue Damage in Murine Pneumococcal Pneumonia
Delay in antibiotic therapy results in fatal disease outcome in murine pneumococcal pneumonia
Delay in antibiotic therapy results in fatal disease outcome in murine pneumococcal pneumonia
Daptomycin in experimental murine pneumococcal meningitis
Simvastatin impairs murine melanoma growth
Btk inhibitor ibrutinib reduces inflammatory myeloid cell responses in the lung during murine pneumococcal pneumonia
The role of pneumolysin in mediating lung damage in a lethal pneumococcal pneumonia murine model
Vasculotide reduces pulmonary hyperpermeability in experimental pneumococcal pneumonia
Pneumococcal pneumonia: differences according to blood culture results
Identification of biomarker signatures for the discrimination of pneumococcal pneumonia from staphylococcal pneumonia
An evaluation of emerging vaccines for childhood pneumococcal pneumonia
Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia
IL-37 Causes Excessive Inflammation and Tissue Damage in Murine Pneumococcal Pneumonia
Delay in antibiotic therapy results in fatal disease outcome in murine pneumococcal pneumonia
Delay in antibiotic therapy results in fatal disease outcome in murine pneumococcal pneumonia
Daptomycin in experimental murine pneumococcal meningitis
Simvastatin impairs murine melanoma growth
Btk inhibitor ibrutinib reduces inflammatory myeloid cell responses in the lung during murine pneumococcal pneumonia
The role of pneumolysin in mediating lung damage in a lethal pneumococcal pneumonia murine model
Vasculotide reduces pulmonary hyperpermeability in experimental pneumococcal pneumonia
Pneumococcal pneumonia: differences according to blood culture results
Identification of biomarker signatures for the discrimination of pneumococcal pneumonia from staphylococcal pneumonia
An evaluation of emerging vaccines for childhood pneumococcal pneumonia
Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia
IL-37 Causes Excessive Inflammation and Tissue Damage in Murine Pneumococcal Pneumonia
Delay in antibiotic therapy results in fatal disease outcome in murine pneumococcal pneumonia
Delay in antibiotic therapy results in fatal disease outcome in murine pneumococcal pneumonia
Daptomycin in experimental murine pneumococcal meningitis
Simvastatin impairs murine melanoma growth
Btk inhibitor ibrutinib reduces inflammatory myeloid cell responses in the lung during murine pneumococcal pneumonia
The role of pneumolysin in mediating lung damage in a lethal pneumococcal pneumonia murine model
Vasculotide reduces pulmonary hyperpermeability in experimental pneumococcal pneumonia
Pneumococcal pneumonia: differences according to blood culture results
Identification of biomarker signatures for the discrimination of pneumococcal pneumonia from staphylococcal pneumonia
An evaluation of emerging vaccines for childhood pneumococcal pneumonia